Countless scientific breakthroughs are made possible in part by preclinical research using animal subjects. Microsampling – the collection of small, precise volumes of blood, as is done using Mitra devices – represents a more humane, more efficient way of doing experimental animal research in the pharmaceutical industry.
Lab that switch to microsampling can save time and money, and better promote the 3Rs of animal research:
Replacement - Improve research methods by replacing some animal experiments with in vitro alternatives
Reduction - Reduce the overall number of animals used and eliminating reliance on satellite populations
Refinement - Use the latest and best in vivo technologies and move toward a more efficient and economical laboratory workflow
The advantages of switching to a microsampling workflow in preclinical workflow are:
Microsampling allows labs to cut costs, simplify processes, and eliminate expensive equipment and time-consuming labor. You can sample from the same animal at multiple time points, generating better data from fewer animals and smaller samples, while working toward the goals of reduction and refinement.
Volumetric absorptive microsampling drives the Mitra® devices originally developed by Neoteryx. The patented VAMS® technology represents a major breakthrough for those working in animal research.